Publication | Closed Access

Combined treatment with SAHA, bortezomib, and clarithromycin for concomitant targeting of aggresome formation and intracellular proteolytic pathways enhances ER stress-mediated cell death in breast cancer cells

Breast OncologyAggresome FormationMedicineApoptosisAutophagyBreast Cancer CellsCell DeathBreast CancerConcomitant TargetingAnti-cancer AgentPharmacologyCell BiologyTumor Microenvironment